Search for stocks /

Sai Life Sciences Q2FY26 Concall Decoded: From Peptides to Profits β€” Sai’s Chemistry Still Cooking πŸ”₯

1. Opening Hook
When most biotech CEOs are blaming β€œmacro headwinds,” Sai Life Sciences’ Krishna Kanumuri basically said, β€œHeadwinds? We turned them into tailwinds.” With China+1 tailwinds, pharma clients lining up, and a peptide pipeline sharper than a chemistry scalpel, Sai seems to have found its growth potion. Biotech slowdown? Offset. Supply chain fears? Monetized. Consultants? Paid in β€œdouble-digit crores.”
The fun starts when they discuss ADCs and oligos β€” apparently everyone’s an expert, but no one knows what’s going on. Read on, because this lab isn’t just bubbling with reactions… it’s also fizzing with ambition.


2. At a Glance

  • Revenue up 53% – CFO insists it’s real, not a chromatography error.
  • EBITDA doubled (β‚Ή281 Cr) – Clearly, chemistry pays better than magic.
  • EBITDA margin 27% – Operating leverage finally kicked in (after caffeine).
  • PAT β‚Ή144 Cr – Molecules weren’t the only thing scaling up.
  • Capex β‚Ή248 Cr (H1) – Expansion spree continues; reactors working overtime.
  • CDMO share 64% – The big pharma crush is real.
  • CRO up 28% – Even biotech winter couldn’t freeze this growth.

3. Management’s Key Commentary

β€œSai Life delivered another strong quarter, continuing positive momentum across Discovery, Development, and Manufacturing.”
(Translation: We didn’t blow up the lab, and the clients are still paying. Success!) 😏

β€œChina+1 and biotech funding slowdown are both opportunities in disguise.”
(Of course, if life gives you geopolitical lemons, make dollar revenue lemonade.)

β€œ35 customer and 3 regulatory audits, zero data integrity deviations.”
(That’s CFO-speak for β€˜no one found the skeletons in the Excel sheets.’)

β€œCapex at β‚Ή248 Cr so far; on track to hit β‚Ή700 Cr for FY26.”
(The reactors are multiplying faster than startup valuations in 2021.)

β€œVeterinary API facility launched β€” partnering with 3 of the top 5 animal health players.”
(Because even cows deserve CRDMO precision, apparently.)

β€œWe’ll never have our own products β€” only work on client projects.”
(Sai’s motto: Be the chemistry partner, not the hero of the movie.)

β€œAI-discovered molecules? Still

Join 10,000+ investors who read this every week.
Become a member
error: Content is protected !!